Morningstar

Matica Bio Secures Commercial Manufacturing Deal with U.S. Biotech Company

COLLEGE STATION, Texas, Sept. 15, 2025 /PRNewswire/ -- Matica Biotechnology, Inc. (Matica Bio), a leading contract development and manufacturing organization (CDMO) specializing in viral vector ...
Business Wire

Matica Bio at BIO International 2024: Leading the Way in CGT Innovation and U.S. Manufacturing Strategy

COLLEGE STATION, Texas--(BUSINESS WIRE)--Matica Biotechnology (Matica Bio) announced today that it will participate in the world’s largest biotech exhibition, the BIO International Convention (BIO USA ...
Business Wire

Treovir and Matica Bio Forms Strategic Partnership to Advance Innovative Therapies for Pediatric Brain Tumors

COLLEGE STATION, Texas--(BUSINESS WIRE)--Matica Biotechnology (Matica Bio), a leading contract development and manufacturing organization (CDMO) specializing in viral vector development and ...
WRIC

Matica Biotechnology Emerges as the Go-To CDMO for Cell & Gene Therapy in 2025

COLLEGE STATION, Texas, Oct. 6, 2025 /PRNewswire/ --Matica Biotechnology, Inc., a U.S.-based Contract Development and Manufacturing Organization (CDMO) specializing in cell and gene therapies (CGT), ...
Reuters

Matica Technologies FY 2014 net profit up 454 pct to EUR 1.9 mln

* FY 2014 EBIT: 2.7 million euros (+170 pct yoy) * 2014 FY revenues: 35.8 million euros (+18 pct yoy) * 2014 FY net profit: 1.9 million euros (+454 pct yoy) Source text for Eikon: Further company ...